Text Size

Rick Halprin, Alcon Global Marketing Manager, Joins Glaucoma Research Foundation Board of Directors

San Francisco, CA, November 16, 2012 — Rick Halprin, CPA, the Global Marketing Manager, Glaucoma, for Alcon Laboratories, Inc., has joined the Board of Directors of Glaucoma Research Foundation (GRF) in San Francisco.

“Rick Halprin’s focus for the past fifteen years has been on identifying unmet medical and surgical needs in glaucoma,” said Andrew G. Iwach, MD, Chair of the Glaucoma Research Foundation Board of Directors. “Rick’s financial background and global perspective will assist the Foundation in achieving our strategic objectives and breadth of reach.”

As Global Marketing Manager, Glaucoma, for Alcon Laboratories, Inc., a Novartis company, Rick is responsible for interactions with thought leaders globally, and assisting in setting strategic direction for Alcon’s glaucoma franchise. Additionally he serves as the industry liaison to numerous eye care societies and congresses. Rick is a graduate of Temple University, the Harvard Program for Management Development, and is a Certified Public Accountant. Rick has also served on the boards of Prevent Blindness, Hill School of Fort Worth, TX, and Junior Achievement.

“Rick’s commitment to improved glaucoma treatments and preserving vision through his work at Alcon makes him an excellent addition to our Board,” said Thomas M. Brunner, President and CEO of the Glaucoma Research Foundation. “Alcon's long-time support of our research and patient education programs has helped so many glaucoma patients over the years. Having Rick’s experience on our Board of Directors will certainly be valuable.”

About Glaucoma Research Foundation

Located in San Francisco, the Glaucoma Research Foundation is the nation’s most experienced foundation dedicated solely to glaucoma research and education. In addition to funding innovative research like the Catalyst for a Cure research consortium and the Shaffer Grants for Innovative Glaucoma Research, GRF provides free educational material including the definitive reference for newly diagnosed patients, “Understanding and Living with Glaucoma,” brochures serving those at highest risk including African Americans and Latinos, and the comprehensive glaucoma.org website that answers patients’ questions about glaucoma.

Last reviewed on October 29, 2017

Was this helpful? Yes No